Rocket Lab’s revenue exceeded expectations by 4%, and its order backlog grew by 52% in a single quarter. While the loss per share was nearly double the forecast, this was largely due to one-time items. The real headline: cash flow from operations has turned positive.
Strong revenue, significant loss
Revenue reached $268 million, surpassing the consensus estimate of $257 million and the company’s own guidance range of $250–$265 million. The loss per share was 12 cents, compared to an expected 7 cents. The gross margin—the portion of revenue remaining after deducting production costs—came in at 34%, exceeding the company’s forecast of 29–31%.
What drove the larger loss
The factors that increased the loss are unrelated to core operations. The retirement of legacy convertible notes cost $27 million, while expenses related to the acquisition of Iridium totaled $21 million. Together, these account for approximately 7 cents per share; excluding them, the loss would have been lower than anticipated. It is also worth noting that the same quarter last year was bolstered by a $41 million tax benefit, making a year-over-year comparison of the loss potentially misleading.
Accelerating growth
Revenue surged 73% year-over-year, with growth accelerating over the last few quarters; product sales nearly doubled, partly driven by recent acquisitions. Although the gross margin is lower than the 37% recorded a year ago, the company had previously signaled this decline. Excluding one-time items, expenses rose by 33%, while revenue climbed 73%—indicating that growth is moving the company closer to profitability, with the adjusted operating loss narrowing from $33 million to $27 million.
Cash flow: turning positive
Cash flow from operations has turned positive, reaching $7 million. In previous quarters, the figure was consistently negative. Customer prepayments played a significant role in this. Meanwhile, inventories and accounts receivable are growing faster than revenue. After accounting for investments, free cash flow—the actual cash remaining—remains negative at approximately $24 million. This year, the company raised $3.9 billion by selling shares to fund the acquisition of Iridium. It currently holds $4.7 billion in cash and has virtually no debt. The trade-off for this position is a 23% increase in the total number of shares outstanding over the past year.
Guidance and the road ahead
The company expects revenue between $270 million and $290 million for the fourth quarter; the midpoint of this range is 5% above the consensus estimate. It is targeting a return to a gross margin of 34%–36%. In recent quarters, the company has consistently delivered results in the upper half of—or even above—its own revenue guidance range. The order backlog stands at $3.6 billion, with approximately $1 billion of that coming from launch contracts signed this quarter. A key risk lies with the Neutron rocket: its maiden flight has been pushed back to 2027 at the earliest. Nevertheless, the rocket has already secured orders for 16 missions, and its launch price has risen to $70 million. The stock climbed 11% during the day but gave back about 7% in after-hours trading; it appears the market initially focused on the loss per share. Key metrics to watch in the next report include maintaining a positive cash position, a return of margins to the projected guidance range, and the successful completion of the Iridium acquisition.